Načítá se...
Meta-Analysis of Rare Adverse Events in Randomized Clinical Trials: Bayesian and Frequentist Methods
BACKGROUND/AIMS: Regulatory approval of a drug or device involves an assessment of not only the benefits but also the risks of adverse events associated with the therapeutic agent. Although randomized controlled trials (RCTs) are the gold standard for evaluating effectiveness, the number of treated...
Uloženo v:
| Vydáno v: | Clin Trials |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8041270/ https://ncbi.nlm.nih.gov/pubmed/33258698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774520969136 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|